Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Markwardt

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Neuroscience Letters|February 25, 2000
Block by extracellular Mg2+ of single human purinergic P2X4 receptor channels expressed in human embryonic kidney cellsY A Negulyaev, F Markwardt
Acta Biologica Et Medica Germanica|January 1, 1978
[Influence of mediators on plasminogen activator release]F Markwardt, H P Klöcking
Biomedica Biochimica Acta|January 1, 1983
Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymesF Markwardt, H P Klöcking
Farmakologiia I Toksikologiia|May 1, 1975
[Thrombolytic and pharmacodynamic properties of Aspergillus ochraceus protease]H P Klöcking, F Markwardt
Haemostasis|January 1, 1977
Heparin-induced release of plasminogen activatorF Markwardt, H P Klöcking
Experientia|April 15, 1984
Acyl-kallikrein; a delivery system for the kinin-liberating enzymeF Markwardt, J Stürzebecher, H Müller
Haemostasis|January 1, 1991
Clinical pharmacology of recombinant hirudinF Markwardt, G Nowak, J Stürzebecher
Cell Calcium|September 5, 2002
Desynchronising effect of the endothelium on intracellular Ca2+ concentration dynamics in vascular smooth muscle cells of rat mesenteric arteriesM Sell, W Boldt, F Markwardt
Haemostasis|January 1, 1987
Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in ratsJ Hauptmann, E Brüggener, F Markwardt
Die Pharmazie|February 1, 1991
Studies on toxicity and pharmacokinetics of the synthetic thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine nitrileB Kaiser, J Hauptmann, F Markwardt
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Neuroscience Letters|February 25, 2000
Block by extracellular Mg2+ of single human purinergic P2X4 receptor channels expressed in human embryonic kidney cellsY A Negulyaev, F Markwardt
Acta Biologica Et Medica Germanica|January 1, 1978
[Influence of mediators on plasminogen activator release]F Markwardt, H P Klöcking
Biomedica Biochimica Acta|January 1, 1983
Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymesF Markwardt, H P Klöcking
Farmakologiia I Toksikologiia|May 1, 1975
[Thrombolytic and pharmacodynamic properties of Aspergillus ochraceus protease]H P Klöcking, F Markwardt
Haemostasis|January 1, 1977
Heparin-induced release of plasminogen activatorF Markwardt, H P Klöcking
Experientia|April 15, 1984
Acyl-kallikrein; a delivery system for the kinin-liberating enzymeF Markwardt, J Stürzebecher, H Müller
Haemostasis|January 1, 1991
Clinical pharmacology of recombinant hirudinF Markwardt, G Nowak, J Stürzebecher
Cell Calcium|September 5, 2002
Desynchronising effect of the endothelium on intracellular Ca2+ concentration dynamics in vascular smooth muscle cells of rat mesenteric arteriesM Sell, W Boldt, F Markwardt
Haemostasis|January 1, 1987
Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in ratsJ Hauptmann, E Brüggener, F Markwardt
Die Pharmazie|February 1, 1991
Studies on toxicity and pharmacokinetics of the synthetic thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine nitrileB Kaiser, J Hauptmann, F Markwardt
Pageof 18